Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & Immunovant CEO
-
Issuer Symbol
-
ROIV on Nasdaq
Eric Venker - trading volume in the past year for Roivant Sciences Ltd.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Option (Right to Buy) |
5,244,834 |
$122,867,295 |
$20.22 |
12 Jan 2026 |
Direct |
Common Stock |
|
| Common Shares |
1,654,597 |
$36,268,766 |
$21.92 |
12 Jan 2026 |
Direct |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.